Liquidia Corporation (LQDA)
Best Momentum Stocks to Buy for May 13th
LQDA, NEXA and NUE made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 13th, 2026.
Liquidia Corporation (LQDA) Q1 2026 Earnings Call Transcript
Liquidia Corporation (LQDA) Q1 2026 Earnings Call Transcript
Liquidia Corporation (LQDA) Surpasses Q1 Earnings and Revenue Estimates
Liquidia Corporation (LQDA) came out with quarterly earnings of $0.52 per share, beating the Zacks Consensus Estimate of $0.34 per share. This compares to a loss of $0.45 per share a year ago.
Best Low-Beta Stocks to Own Right Away: LQDA, CBOE, VLO & FANG
Low beta screen highlights LQDA, CBOE, VLO and FANG as Middle East tensions keep U.S. stocks volatile, and investors favor steadier movers.
Does Liquidia Corporation (LQDA) Have the Potential to Rally 34.47% as Wall Street Analysts Expect?
The mean of analysts' price targets for Liquidia Corporation (LQDA) points to a 34.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Can Liquidia Corporation (LQDA) Run Higher on Rising Earnings Estimates?
Liquidia Corporation (LQDA) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Wall Street Analysts See a 35.35% Upside in Liquidia Corporation (LQDA): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 35.4% in Liquidia Corporation (LQDA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Best Momentum Stocks to Buy for March 10th
STRL, LQDA and NWPX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 10th, 2026.
Liquidia Corporation (LQDA) Surpasses Q4 Earnings and Revenue Estimates
Liquidia Corporation (LQDA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to a loss of $0.46 per share a year ago.
Liquidia Appears Set For Strong 2026 On Further Share Gains
Liquidia has rapidly captured 16% market share in pulmonary hypertension since launching Yutrepia in June 2025, with momentum likely to continue. LQDA's superior product profile is driving patient switches from United Therapeutics, supporting robust revenue and cash flow growth projections. Assuming 50% market share and 20% market growth, LQDA could be trading at under 7x cash flow by year-end 2026, implying material undervaluation.
Liquidia Corporation (LQDA) is a Great Momentum Stock: Should You Buy?
Does Liquidia Corporation (LQDA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Liquidia Corporation (LQDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
